)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
COSMOS Pharmaceutical
COSMOS Pharmaceutical (3349) investor relations material
COSMOS Pharmaceutical Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2027 earnings summary13 Oct, 2026
Executive summary
Q1 FY2027 net sales rose 5.2% YoY to ¥286,653 million; operating profit rose 3.1% to ¥12,005 million and profit attributable to owners of parent rose 1.0% to ¥8,251 million.
Store expansion and low-cost operations supported results amid inflation, yen weakness and Middle East-related oil supply concerns.
Financial highlights
Gross profit increased to ¥62,129 million from ¥57,174 million; SG&A rose to ¥50,124 million from ¥45,529 million.
EBITDA was ¥17,911 million, up 5.7% YoY; ordinary profit was ¥12,766 million, up 4.7%.
Extraordinary losses totaled ¥407 million, including ¥204 million from disaster losses and ¥91 million from store closings.
Outlook and guidance
FY2027 guidance remains unchanged: net sales ¥1,190,000 million (+8.2%), operating profit ¥43,000 million (+1.5%), ordinary profit ¥45,700 million (+2.4%) and parent profit ¥30,700 million (-4.2%).
H1 guidance: net sales ¥582,700 million (+8.5%), operating profit ¥20,780 million (+0.5%), ordinary profit ¥22,180 million (+1.1%) and parent profit ¥14,480 million (-1.2%).
FY2027 forecast EPS is ¥387.35; H1 forecast EPS is ¥182.70. Forecasts are subject to risks and assumptions, and actual results may differ significantly.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from COSMOS Pharmaceutical
- Sales and profits rose on store growth, with FY2027 guidance for higher sales and dividends.3349
Q4 2026 - Net sales rose 7.7% and profit attributable to owners increased 1.8% year-over-year.3349Q3 2026
- Strong sales and profit growth achieved through expansion and operational efficiency.3349Q2 2025
- Sales and profits rose modestly, with strong store expansion and stable financial outlook.3349Q2 2026
- Strong sales and profit growth, with continued expansion and a 2-for-1 stock split planned.3349Q4 2024
- Strong sales and profit growth achieved despite economic headwinds, with positive full-year outlook.3349Q1 2025
- Strong profit growth and store expansion achieved amid economic headwinds and rising costs.3349Q3 2025
- Strong profit growth and continued store expansion drive positive outlook and higher dividends.3349Q4 2025
- Net sales rose 4.0% and operating profit edged up 0.6% year-over-year, with 12 new stores opened.3349Q1 2026
Next COSMOS Pharmaceutical earnings date
Q2 20278 Jan, 2027
COSMOS Pharmaceutical
Next COSMOS Pharmaceutical earnings date
Q2 20278 Jan, 2027
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage